Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05581511 · ClinicalTrials.gov registry record
Natural History Study of Cutaneous Neurofibromas in People With NF1
A clinical trial of Neurofibromatosis 1 and Neurofibromatosis Type 1, sponsored by Johns Hopkins University.
- Active
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT05581511: Active study of Neurofibromatosis 1 and Neurofibromatosis Type 1, sponsored by Johns Hopkins University.
NCT05581511 is a study of Neurofibromatosis 1 and Neurofibromatosis Type 1 that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 500 participants, below the 1,015-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05581511, a study of Neurofibromatosis 1 and Neurofibromatosis Type 1, is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
People diagnosed with NF1 may develop cutaneous neurofibromas, also known as cNFs. These benign tumors can cause discomfort and affect a person's quality of life. Researchers at Johns Hopkins are studying how cNF tumors form, grow and change over time. This information may help doctors in the future, provide early interventions and improve quality of life for NF1 patients. Researchers will also explore a new way of monitoring cNF with 3D camera technology. People of all ages with NF1, living in the United States, are invited to participate in this important research study.
Primary Outcome
To characterize the baseline tumor burden of cNFs
Conditions Studied
Interventions
- OTHER Evaluation of the natural history of cutaneous neurofibromas
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2029-06-30 |
What the registry record for NCT05581511 still lists
NCT05581511 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,015-participant average among 24 other Neurofibromatosis 1 trials with a reported enrollment target (51% lower).
The record links to 4 conditions, with Neurofibromatosis 1 appearing as the primary indexed condition, and to 1 intervention - of which Evaluation of the natural history of cutaneous neurofibromas is the first listed.
NCT05581511 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05581511 about?
NCT05581511 is a clinical study titled "Natural History Study of Cutaneous Neurofibromas in People With NF1". People diagnosed with NF1 may develop cutaneous neurofibromas, also known as cNFs. These benign tumors can cause discomfort and affect a person's quality of life. Researchers at Johns Hopkins are studying how cNF tumors form, grow and change over time. This information may help doctors in the future...
What is the current status of trial NCT05581511?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2021-06-28. Estimated completion is 2029-06-30.
What conditions does trial NCT05581511 study?
This clinical trial studies the following conditions: Neurofibromatosis 1, Neurofibromatosis Type 1, Cutaneous Neurofibroma, Neurofibromatosis (Nonmalignant).
What interventions are being tested in trial NCT05581511?
The interventions under investigation include: Evaluation of the natural history of cutaneous neurofibromas (OTHER).
Who is sponsoring clinical trial NCT05581511?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05581511 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurofibromatosis 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05581511's enrollment target sits among peer trials
500 4th of 24 higher than 21 of 24 other Neurofibromatosis 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neurofibromatosis 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
RECRUITING · NA
-
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
RECRUITING · NA
-
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
RECRUITING
-
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RECRUITING · Phase 1
-
Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
RECRUITING · NA
-
Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI